Company · CIK 1718644

# Zander Therapeutics, Inc

| CIK | [1718644](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001718644) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | NV |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2018-09-26 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-220790 | First-time registration Effective | 2017-10-04 | 2018-05-30 | 6 |

## Filings

 6

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2018-05-30 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1718644/999999999518001374/9999999995-18-001374-index.htm) Declared effective | 333-220790 | 9999999995-18-001374 |
| 2018-04-25 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1718644/000160706218000140/0001607062-18-000140-index.htm) Amendment | 333-220790 | 0001607062-18-000140 |
| 2018-04-13 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1718644/000160706218000117/0001607062-18-000117-index.htm) Amendment | 333-220790 | 0001607062-18-000117 |
| 2018-03-20 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1718644/000160706218000086/0001607062-18-000086-index.htm) Amendment | 333-220790 | 0001607062-18-000086 |
| 2018-01-16 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1718644/000160706218000021/0001607062-18-000021-index.htm) Amendment | 333-220790 | 0001607062-18-000021 |
| 2017-10-04 | [S-1](https://www.sec.gov/Archives/edgar/data/1718644/000160706217000323/0001607062-17-000323-index.htm) Registration filed | 333-220790 | 0001607062-17-000323 |

[All filings of this company](https://equitycapital.markets/filings?cik=1718644) · [CSV](https://equitycapital.markets/filings.csv?cik=1718644)

---
Source page: https://equitycapital.markets/company/1718644 · Data: U.S. SEC EDGAR · CC BY 4.0